Equilibrium asset pricing with Epstein-Zin and loss-averse investors
From MaRDI portal
Publication:1655625
DOI10.1016/J.JEDC.2016.12.008zbMath1401.91074OpenAlexW3122171757MaRDI QIDQ1655625
Publication date: 9 August 2018
Published in: Journal of Economic Dynamics \& Control (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jedc.2016.12.008
loss aversionheterogeneous agentsrecursive utilitymarket dominanceequilibrium asset pricinggain-loss ratio
Related Items (3)
Equilibrium variance risk premium in a cost-free production economy ⋮ A new preference model that allows for narrow framing ⋮ The loss-averse newsvendor problem with quantity-oriented reference point under CVaR criterion
Cites Work
- Unnamed Item
- Financial market equilibria with heterogeneous agents: CAPM and market segmentation
- Dynamic portfolio choice and asset pricing with narrow framing and probability weighting
- Financial market equilibria with cumulative prospect theory
- Loss aversion, survival and asset prices
- Advances in prospect theory: cumulative representation of uncertainty
- Evolution and market behavior
- Discrete-time behavioral portfolio selection under cumulative prospect theory
- Preferences with frames: A new utility specification that allows for the framing of risks
- Prospect theory and market quality
- Prospect Theory and Asset Prices
- Portfolio Choice Under Cumulative Prospect Theory: An Analytical Treatment
- Natural Selection in Financial Markets: Does It Work?
- Dynamic Trading with Reference Point Adaptation and Loss Aversion
- Temporal Resolution of Uncertainty and Dynamic Choice Theory
- Prospect Theory: An Analysis of Decision under Risk
- Do Markets Favor Agents able to Make Accurate Predictions?
- Substitution, Risk Aversion, and the Temporal Behavior of Consumption and Asset Returns: A Theoretical Framework
- Myopic Loss Aversion and the Equity Premium Puzzle
- Myopic loss aversion, reference point, and money illusion
- ARROW–DEBREU EQUILIBRIA FOR RANK‐DEPENDENT UTILITIES
This page was built for publication: Equilibrium asset pricing with Epstein-Zin and loss-averse investors